Stephen P. Carey

Senior Vice President, Finance and Chief Financial OfficeratAni Pharmaceuticals· In proxies 2021–2025

Pay in FY2025+14% from the year before · Ani Pharmaceuticals stock +42.8% the same year

Stephen P. Carey was paid $3.3M in FY2025 (Dec), up 14%. Ani Pharmaceuticals stock rose 42.8% that year.

Pay$100 in the stock at the end of FY20 → $272

Pay is from the Summary Compensation Table of each Ani Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

Ani PharmaceuticalsPublic company · 5 yr
- Senior Vice President, Finance and Chief Financial Officer2021 – Present · 5 yrStock in role +156%

Roles come from the proxy statements of each company.

Activity

Pay
Ani Pharmaceuticals CFO pay rose 14% to $3.3M. The stock rose 43% in FY2025 (Dec).
DEF 14AApr 9, 2026
Pay
Ani Pharmaceuticals CFO pay rose 11% to $2.9M. The stock did not change in FY2024 (Dec).
DEF 14AApr 10, 2025
Pay
Ani Pharmaceuticals CFO pay rose 26% to $2.6M. The stock rose 37% in FY2023 (Dec).
DEF 14AApr 5, 2024
Pay
Ani Pharmaceuticals CFO pay fell 28% to $2.0M. The stock fell 13% in FY2022 (Dec).
DEF 14AApr 5, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?